These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1467 related articles for article (PubMed ID: 24671016)

  • 21. Effects of different antihypertensive medication groups on cognitive function in older patients: A systematic review.
    Stuhec M; Keuschler J; Serra-Mestres J; Isetta M
    Eur Psychiatry; 2017 Oct; 46():1-15. PubMed ID: 28992530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2018 Aug; 36(8):1637-1647. PubMed ID: 29847487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
    Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
    Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative analysis of the combined treatment efficacy of the Chernobyl accident clean-up workers with essential hypertension].
    Habulavichene ZhM
    Lik Sprava; 2012 Dec; (8):21-9. PubMed ID: 23786006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative risk of new-onset diabetes mellitus for antihypertensive drugs in elderly: A Bayesian network meta-analysis.
    Zhang J; Tong A; Dai Y; Niu J; Yu F; Xu F
    J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1082-1090. PubMed ID: 31241860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
    JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up.
    Fici F; Seravalle G; Koylan N; Nalbantgil I; Cagla N; Korkut Y; Quarti-Trevano F; Makel W; Grassi G
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):289-296. PubMed ID: 28497339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis.
    Pongpanich P; Pitakpaiboonkul P; Takkavatakarn K; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
    Int Urol Nephrol; 2018 Dec; 50(12):2261-2278. PubMed ID: 30324578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive medication class and pulse pressure in the elderly: analysis based on the third National Health and Nutrition Examination Survey.
    Chang JJ; Luchsinger JA; Shea S
    Am J Med; 2003 Nov; 115(7):536-42. PubMed ID: 14599632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of hypotensive drugs on the circadian blood pressure pattern in essential hypertension: a comparative study.
    Zakopoulos N; Stamatelopoulos S; Moulopoulos S
    Cardiovasc Drugs Ther; 1997 Dec; 11(6):795-9. PubMed ID: 9512875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the effects of fixed dose vs. single-agent combinations on 24-h blood pressure variability.
    Ulusoy S; Ozkan G; Konca C; Kaynar K
    Hypertens Res; 2012 Nov; 35(11):1111-7. PubMed ID: 22786565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in antihypertensive treatment--lessons from the National Acute Stroke Israeli (NASIS) registry.
    Koifman E; Tanne D; Molshatzki N; Leibowitz A; Grossman E
    Blood Press; 2014 Oct; 23(5):262-9. PubMed ID: 24483945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence of treatment and blood pressure control in elderly hypertensive patients treated with different classes of antihypertensive drugs.
    Borghi C; Veronesi M; Dormi A; Prandin MG; Cosentino E; Strocchi E
    Am J Geriatr Cardiol; 2007; 16(5):280-6. PubMed ID: 17786056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive treatment for hypertensive patients with heart failure using real-world Japanese data: subanalysis of the Retrospective study of antihypertensives for lowering blood pressure (REAL) study.
    Ohishi M; Yoshida T; Nishigaki N; Oh A; Shimasaki Y
    Clin Exp Hypertens; 2020; 42(2):139-145. PubMed ID: 30912679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension.
    Chen JM; Heran BS; Perez MI; Wright JM
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007185. PubMed ID: 20091622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 74.